Use: Labeled indications
- Adults and children 7 years and older: Spray into the nose 3 times a day
Full indications and usage US FDA label
Adults and children 7 years and older: Spray into the nose 3 times a day
Dosing: Adult
Dosage and administration (US label) US FDA label
for nasal use
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Nasal solution: 1 mg/mL, 500 mcg/mL
- Nasal spray: 10 mg/10 mL, 500 mcg/mL
- Nasal spray solution: 1 mg/mL, 10 mg/10 mL
- Nasal drops: 1 mg/mL
Registered products in the Philippines
11 products registered with the Food and Drug Administration (FDA) Philippines list Xylometazoline as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Xylometazoline HCI (1 product). Products registered under these spellings are included in the table and marked.
All registered products11
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
1mg/mL Nasal SolutionHDPE Bottle x 15mL (Box of 1's) | OTC | Taiguk Pharma, Co., Ltd.Korea | Importer: H & B Pharma International Inc. | DRP-11213 | Feb 15, 2027 | ||
NoneXylometazoline Hydrochloride | 1 mg/mL (0.1% w/v) Nasal SolutionHDPE/LDPE Plastic Dropper Bottle x 10 mL (Box of 1's) | OTC | West-Coast Pharmaceutical Works Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-6104-01 | Apr 16, 2030 | |
XylometXylometazoline hydrochloride | 1 mg/mL (0.1%) Nasal Spray SolutionHDPE White Plastic Bottle x 15 mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Nurturemed Pharma, Inc. | DR-XY38925 | Jan 10, 2031 | |
XylonasXylometazoline Hydrochloride | 1 mg/mL (0.1% w/v) Nasal Solution (Drops) | OTC | Geofman Pharmaceuticals | Sahar International Trading Inc. | DR-XY40321 | Nov 21, 2026 | |
XyloneXylometazoline Hydrochloride | 1 mg/mL (0.1% w/v) Nasal SolutionHDPE/LDPE plastic dropper bottle x 10 mL (Box of 1's) | OTC | West-Coast Pharmaceutical Works Ltd.India | Scheeling, Inc.Importer: Ambica International Corporation | DRP-6104 | Apr 16, 2030 | |
XytasaphXylometazoline hydrochloride | 1 mg/mL (0.10% w/v) Nasal DropsWhite HDPE Plastic Dropper Bottle x 10 mL and 15 mL (Box of 1's) | OTC | Kilitch Drugs (India) Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14080 | Jun 16, 2028 | |
XytasaphXylometazoline hydrochloride | 500 mcg/mL (0.05% w/v) Nasal Solution (Drops)White HDPE Plastic Dropper Bottle x 10 mL and 15 mL (Box of 1's) | OTC | Kilitch Drugs (India) Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14079 | Jun 16, 2028 | |
ZynasaloXylometazoline Hydrochloride | 10 mg/10mL (0.1% w/v) Nasal Spray SolutionLDPE nasal bottle 10mL box of 1's | OTC | Ebe Pharmaceutical Co., Ltd.China | Aglobal Care, Inc. | DRP-12570 | Sep 12, 2027 | |
ZynasaloXylometazoline Hydrochloride | 10 mg/10mL Nasal Spray10 mL LDPE Nasal Spray Bottle (Box of 1's) | OTC | Ebe Pharmaceutical Co., Ltd.China | Aglobal Care, Inc. | DRP-13362 | Feb 3, 2028 | |
ZynasaloXylometazoline (as Hydrochloride) | 500 mcg/mL (0.05 % w/v) Nasal Solution (Drops)LDPE Plastic Bottle x 10 mL (Box of 1's) | OTC | EBE PHARMACEUTICAL CO., LTD.China | Aglobal Care, Inc. | DRP-14212 | Jul 27, 2028 | |
ZynasaloXylometazoline (as Hydrochloride) | 500 mcg/mL (0.05 % w/v) Nasal SprayHDPE Spray Bottle x 10 mL (Box of 1's) | OTC | EBE PHARMACEUTICAL CO., LTD.China | Aglobal Care, Inc. | DRP-14213 | Jul 27, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
■ When using this product Stop use and ask a doctor if nervousness, diziness, or sleepness occur. Pain, nasal congestion or cough gets worse or lasts more than 7 days. fever gets worse or lasts more than 3 days New symtoms occur. keep out of reach of children. In case of overdose, get medical help or contact a poison contral center right away. If pregnant or breast-feeding, ask a health professional before use.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Metarivin Soln. 0.1% · Lydia Co., Ltd. [US FDA-approved label, version 2, September 30, 2022]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9da6f39-8620-faca-e053-2995a90a8a57
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .